Vicryl Plus and Vicryl Sutures in Reduce of Infection in Dental Implant Surgery
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 320
- 主要终点
- The prevalence of post-operative infection
研究概览
简要总结
Patients randomly aligned in 2 groups.Vicryl plus sutures were used in group 1 for closing subperiostal flaps after dental implant surgeries and vicryl sutures were used in group 2.
详细描述
Patients were divided randomly based on computer randomization list in two groups: In group1, vicryl plus 4-0 (Vicryl Plus Ethicon,Johnson & Johnson Company, Sommerville, NJ) suture was used to close surgical site and Vicryl 4-0 (Vicryl Ethicon,Johnson & Johnson Company, Sommerville, NJ) in group II.
All dental implants were placed through creating subperiosteal flaps. In each group, fresh socket placed dental implants were documented. Patients were visited in 1, 2, 3 and 4 weeks after dental implant surgeries.
Postoperative infection was defined as local erythematous change in the sutured wound with purulent discharge or localized abscess formation on surgical site. If wound dehiscence occurred, it was documented.
Patients were blind about what suture was used.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Single (Participant)
盲法说明
Patients were blind about kind of sutures which were used to close flaps.
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Need 3 dental implants at the posterior of the mandible
排除标准
- •Diabetic patients
- •poor oral hygiene
研究组 & 干预措施
Vicryl plus
In this group, vicryl plus(Triclosan coated) sutures were used to close flaps
干预措施: Vicryl plus (Drug)
结局指标
主要结局
The prevalence of post-operative infection
时间窗: In one month
The number of participants who had local erythematous change in the sutured wound with purulent discharge or localized abscess formation on surgical site.
The prevalence of post-operative dehiscence
时间窗: In one month
The number of participants who had relatively or completely open wound
次要结局
未报告次要终点
研究者
Reza Tabrizi
Associate professor of OMFS
Shiraz University of Medical Sciences
